TUMOUR BUDDING-AN ADDITIONAL PROGNOSTIC FACTOR IN COLORECTAL CANCER SURVIVAL

被引:3
作者
Kamali, Gulcin Harman [1 ]
Ulusoy, Cemal [2 ]
Nikolovski, Andrej [3 ,4 ]
Kamali, Sedat [2 ]
机构
[1] Prof Dr Cemil Tascioglu Sehir Hastanesi, Dept Pathol, Istanbul, Turkiye
[2] Prof Dr Cemil Tascioglu Sehir Hastanesi, Dept Gen Surg, Istanbul, Turkiye
[3] Univ Clin Surg Sv Naum Ohridski Skopje, Dept Visceral Surg, Skopje, North Macedonia
[4] Univ Clin Surg Sv Naum Ohridski, Dept Visceral Surg, Bul 11 Oktomvri 53, Skopje 1000, North Macedonia
关键词
colorectal cancer; prognosis; survival; tumour budding; INVOLVEMENT;
D O I
10.5114/pjp.2023.127040
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Tumour budding (TB) in cancer is a phenomenon of tumour cells forming clusters, and it is associated with an epithelial-mesenchymal transition into the extracellu-lar matrix of the tumour. It has been shown that the presence of TB in colorectal cancer (CRC) is associated with worse overall survival, higher possibility for vessel invasion, lymph node involvement, and distant metastases appearance. In this retrospective study TB presence in operated patients for CRC is analysed. In the data from 81 patients, 26 presented with TB.Analysis revealed high statistical significance of the effect of TB presence on the num-ber of metastatic lymph nodes, and the lymphovascular and perineural invasion. A statistically meaningful correlation was found between the presence of TB and CRC survival (p = 0.016). Patients with right-sided colon cancer presented with worse overall survival (p = 0.011). The patients who presented lymph node metastases and TB presence had worse overall survival (p = 0.026 andp = 0.021, respectively). Tumour budding, tumour location, and age over 64 years are found to be the in-dependent prognostic factors in CRC patients. Tumour budding is an important prognostic factor in CRC patients that will contribute to treatment. Pathological examination must consider TB in detail.
引用
收藏
页码:36 / 41
页数:6
相关论文
共 29 条
[1]  
American Joint Committee on Cancer, 2017, AJCC Cancer staging manual, V8
[2]   Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR) [J].
Basile, D. ;
Broudin, C. ;
Emile, J. F. ;
Falcoz, A. ;
Pages, F. ;
Mineur, L. ;
Bennouna, J. ;
Louvet, C. ;
Artru, P. ;
Fratte, S. ;
Ghiringhelli, F. ;
Andre, T. ;
Derangere, V ;
Vernerey, D. ;
Taieb, J. ;
Svrcek, M. .
ANNALS OF ONCOLOGY, 2022, 33 (06) :628-637
[3]   Tumor budding as a risk factor for nodal metastasis in pT1 colorectal cancers: a meta-analysis [J].
Cappellesso, Rocco ;
Luchini, Claudio ;
Veronese, Nicola ;
Lo Mete, Marcello ;
Rosa-Rizzotto, Erik ;
Guido, Ennio ;
De lazzari, Franca ;
Pilati, Pierluigi ;
Farinati, Fabio ;
Realdon, Stefano ;
Solmi, Marco ;
Fassan, Matteo ;
Rugge, Massimo .
HUMAN PATHOLOGY, 2017, 65 :62-70
[4]   Pathological Features and Prognostication in Colorectal Cancer [J].
Chen, Kabytto ;
Collins, Geoffrey ;
Wang, Henry ;
Toh, James Wei Tatt .
CURRENT ONCOLOGY, 2021, 28 (06) :5356-5383
[5]   Prognostic significance of poorly differentiated clusters and tumor budding in colorectal liver metastases [J].
Fonseca, Gilton M. ;
de Mello, Evandro S. ;
Faraj, Sheila F. ;
Kruger, Jaime A. P. ;
Coelho, Fabricio F. ;
Jeismann, Vagner B. ;
Lupinacci, Renato M. ;
Cecconello, Ivan ;
Alves, Venancio A. F. ;
Pawlik, Timothy M. ;
Herman, Paulo .
JOURNAL OF SURGICAL ONCOLOGY, 2018, 117 (07) :1364-1375
[6]   Tumour budding, poorly differentiated clusters, and T-cell response in colorectal cancer [J].
Fujiyoshi, Kenji ;
Vayrynen, Juha P. ;
Borowsky, Jennifer ;
Papke, David J., Jr. ;
Arima, Kota ;
Haruki, Koichiro ;
Kishikawa, Junko ;
Akimoto, Naohiko ;
Ugai, Tomotaka ;
Lau, Mai Chan ;
Gu, Simeng ;
Shi, Shanshan ;
Zhao, Melissa ;
Da Silva, Annacarolina Fabiana Lucia ;
Twombly, Tyler S. ;
Nan, Hongmei ;
Meyerhardt, Jeffrey A. ;
Song, Mingyang ;
Zhang, Xuehong ;
Wu, Kana ;
Chan, Andrew T. ;
Fuchs, Charles S. ;
Lennerz, Jochen K. ;
Giannakis, Marios ;
Nowak, Jonathan A. ;
Ogino, Shuji .
EBIOMEDICINE, 2020, 57
[7]  
Gao Z, 2021, WORLD J SURG ONCOL, V3, P1
[8]   Tumor Budding in Colorectal Carcinoma Confirmation of Prognostic Significance and Histologic Cutoff in a Population-based Cohort [J].
Graham, Rondell P. ;
Vierkant, Robert A. ;
Tillmans, Lori S. ;
Wang, Alice H. ;
Laird, Peter W. ;
Weisenberger, Daniel J. ;
Lynch, Charles F. ;
French, Amy J. ;
Slager, Susan L. ;
Raissian, Yassaman ;
Garcia, Joaquin J. ;
Kerr, Sarah E. ;
Lee, Hee Eun ;
Thibodeau, Stephen N. ;
Cerhan, James R. ;
Limburg, Paul J. ;
Smyrk, Thomas C. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (10) :1340-1346
[9]   CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway [J].
Graule, Janina ;
Uth, Kristin ;
Fischer, Elia ;
Centeno, Irene ;
Galvan, Jose A. ;
Eichmann, Micha ;
Rau, Tilman T. ;
Langer, Rupert ;
Dawson, Heather ;
Nitsche, Ulrich ;
Traeger, Peter ;
Berger, Martin D. ;
Schnuriger, Beat ;
Hadrich, Marion ;
Studer, Peter ;
Inderbitzin, Daniel ;
Lugli, Alessandro ;
Tschan, Mario P. ;
Zlobec, Inti .
CLINICAL EPIGENETICS, 2018, 10 :120
[10]   PROGNOSTIC VALUE OF TUMOR BUDDING IN PATIENTS WITH COLORECTAL-CANCER [J].
HASE, K ;
SHATNEY, C ;
JOHNSON, D ;
TROLLOPE, M ;
VIERRA, M .
DISEASES OF THE COLON & RECTUM, 1993, 36 (07) :627-635